Table 4.
ECVs for amphotericin B, flucytosine, and itraconazole and eight Candida species
Species | Antifungal agent | Incubation time (h) | No. of isolates tested | MIC μg/ml |
ECV (μg/ml) (%a) | |
---|---|---|---|---|---|---|
Range | Mode | |||||
C. albicans | Amphotericin B | 24 | 9,252 | ≤0.03–4 | 0.5 | 2 (99.8) |
48 | 11,554 | ≤0.03–≥8 | 1 | 2 (99.2) | ||
Flucytosine | 24 | 8,007 | ≤0.06–≥64 | 0.06 | 0.5 (94.2) | |
48 | 7,241 | ≤0.06–≥64 | 0.12 | 1 (91.4) | ||
Itraconazole | 24 | 14,716 | ≤0.008–≥8 | 0.03 | 0.12 (95.0) | |
48 | 14,298 | ≤0.008–≥8 | 0.03 | 0.12 (92.9) | ||
C. glabrata | Amphotericin B | 24 | 3,117 | ≤0.03–4 | 1 | 2 (99.6) |
48 | 3,451 | ≤0.03–4 | 1 | 2 (98.7) | ||
Flucytosine | 24 | 3,387 | ≤0.06–≥64 | 0.12 | 0.5 (98.0) | |
48 | 2,981 | ≤0.06–≥64 | 0.12 | 0.5 (97.5) | ||
Itraconazole | 24 | 5,796 | ≤0.008–≥8 | 0.5 | 2 (95.7) | |
48 | 5,846 | ≤0.008–≥8 | 1 | 4 (97.9) | ||
C. parapsilosis | Amphotericin B | 24 | 3,107 | ≤0.03–4 | 1 | 2 (99.7) |
48 | 3,391 | ≤0.03–4 | 1 | 2 (97.3) | ||
Flucytosine | 24 | 3,165 | ≤0.06–32 | 0.12 | 0.5 (98.7) | |
48 | 2,274 | ≤0.06–≥64 | 0.12 | 0.5 (97.8) | ||
Itraconazole | 24 | 4,894 | ≤0.008–≥8 | 0.12 | 0.5 (99.7) | |
48 | 4,643 | ≤0.008–≥8 | 0.12 | 0.5 (98.5) | ||
C. tropicalis | Amphotericin B | 24 | 2,062 | ≤0.03–4 | 1 | 2 (99.8) |
48 | 2,373 | ≤0.03–≥8 | 1 | 2 (99.2) | ||
Flucytosine | 24 | 2,046 | ≤0.06–≥64 | 0.12 | 0.5 (93.0) | |
48 | 1,588 | ≤0.06–≥64 | 0.25 | 1 (90.5) | ||
Itraconazole | 24 | 3,624 | ≤0.008–≥8 | 0.06 | 0.5 (97.8) | |
48 | 3,231 | ≤0.008–≥8 | 0.12 | 0.5 (93.9) | ||
C. krusei | Amphotericin B | 24 | 577 | ≤0.03–4 | 1 | 2 (99.3) |
48 | 611 | 0.06–4 | 1 | 4 (100.0) | ||
Flucytosine | 24 | 499 | ≤0.06–≥64 | 8 | 32 (99.4) | |
48 | 419 | ≤0.06–≥64 | 16 | 32 (99.3) | ||
Itraconazole | 24 | 809 | ≤0.008–2 | 0.25 | 1 (99.0) | |
48 | 793 | ≤0.008–2 | 0.5 | 2 (100.0) | ||
C. lusitaniae | Amphotericin B | 24 | 71 | 0.06–2 | 1 | 2 (100.0) |
48 | 93 | 0.12–4 | 2 | 4 (100.0) | ||
Flucytosine | 24 | 85 | ≤0.06–≥64 | 0.12 | 0.5 (95.3) | |
48 | 98 | ≤0.06–≥64 | 0.12 | 1 (92.9) | ||
Itraconazole | 24 | 119 | ≤0.008–1 | 0.12 | 0.5 (95.8) | |
48 | 104 | 0.016–1 | 0.12 | 0.5 (98.1) | ||
C. dubliniensis | Amphotericin B | 48 | 75 | ≤0.03–2 | 0.5–1 | 2 (100.0) |
Flucytosine | 24 | 84 | 0.12–1 | 0.12 | 0.5 (98.8) | |
48 | 44 | 0.12–1 | 0.12 | 0.5 (97.7) | ||
Itraconazole | 24 | 85 | ≤0.008–0.5 | 0.03 | 0.25 (97.6) | |
48 | 130 | ≤0.008–0.5 | NMb | 0.25 (96.9) | ||
C. guilliermondii | Amphotericin B | 24 | 47 | 0.25–2 | 0.5 | 2 (100.0) |
48 | 83 | 0.06–2 | 0.5 | 2 (100.0) | ||
Flucytosine | 24 | 41 | 0.12–8 | 0.12 | 1 (92.7) | |
Itraconazole | 24 | 61 | 0.016–1 | 0.5 | 1 (100.0) | |
48 | 40 | 0.016–2 | 0.5 | 2 (100.0) |
Percentage of isolates at less than or equal to the ECV (epidemiological cutoff value; μg/ml).
NM, no mode.